Targeting leukemic stem cells by breaking their dormancy

Molecular Oncology - Tập 4 - Trang 443-450 - 2010
Marieke Alida Gertruda Essers1, Andreas Trumpp1
1HI-STEM (Heidelberg Institute for Stem Cell Technology and Experimental Medicine), Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany

Tóm tắt

AbstractTransient or long‐term quiescence, the latter referred to as dormancy are fundamental features of at least some adult stem cells. The status of dormancy is likely a critical mechanism for the observed resistance of normal HSCs and leukemic stem cells (LSCs) to anti‐proliferative chemotherapy. Recent studies have revealed cytokines such as Interferon‐alpha (IFNα) and G‐CSF as well as arsenic trioxide (As2O3) to be efficient agents for promoting cycling of dormant HSCs and LSCs. Most interestingly, such cell cycle activated stem cells become exquisitely sensitive to killing by different chemotherapeutic agents, suggesting that dormant LSCs in patients may be targeted by a sequential two‐step protocol involving an initial activation by IFNα, G‐CSF or As2O3, followed by targeted chemotherapy.

Tài liệu tham khảo

10.1038/nrc2256 10.1038/nrd2422 10.1016/j.gde.2008.01.017 10.1189/jlb.69.6.912 10.1182/blood-2008-08-077941 10.1038/leu.2009.43 10.1038/456581a 10.1016/j.devcel.2005.03.019 10.1038/nature07815 10.1038/nbt.1517 10.1016/j.cell.2009.05.002 10.1182/blood-2007-04-038943 10.1016/j.beha.2009.08.001 10.1038/leu.2009.142 10.1016/S0092-8674(02)00754-7 10.1038/nature07016 10.1016/j.gde.2009.01.004 10.1158/1078-0432.CCR-05-0429 10.1126/science.1142596 10.1016/j.cell.2005.05.026 10.1016/j.stem.2007.10.001 McDermott S.P. Eppert K. Lechman E. Doedens M. Dick J.E. 2010. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood. Epub ahead of print. 10.1073/pnas.94.5.1908 10.1038/nm.1891 10.1158/1078-0432.CCR-09-0209 10.1126/science.273.5272.242 10.1038/nm0109-23 10.1038/ni813 10.1038/nature07567 10.1038/35102167 10.1038/nm1487 10.1182/blood-2006-03-011239 10.1038/nbt.1607 10.1038/nm.1973 10.1146/annurev.med.54.101601.152334 10.1038/nri2726 10.1038/ncponc1110 10.1371/journal.pone.0006972 10.1371/journal.pbio.0020301 10.1016/j.tcb.2005.07.004 10.1016/j.cell.2008.10.048 10.1016/j.gde.2009.08.005 10.1196/annals.1392.021 10.1016/j.stem.2009.08.013 10.1038/sj.emboj.7601236 10.1126/science.1183424 10.1038/nrd2137
Thông tin
Thông tin xuất bản

Molecular Oncology

Tập 4

443-450

Thông tin tác giả